Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Non-Small-Cell Lung Cancer – Unmet Need – Unmet Need – Metastatic Squamous Non-Small-Cell Lung Cancer (US/EU)
With only a small percentage of patients harboring a biomarker-driven metastatic squamous non-small-cell lung cancer (NSCLC) (about 10% of all patients in the G7 countries), the preferred first-…
Breast Cancer – Unmet Need – Unmet Need – Metastatic HR-Positive / HER2-Negative Breast Cancer (US/EU)
The treatment landscape for advanced HR-positive / HER2-negative breast cancer is continually evolving. CDK4/6 inhibitors, such as Pfizer’s Ibrance and Novartis’s Kisqali, are commonly used…
Idiopathic Pulmonary Fibrosis – Unmet Need – Unmet Need – Idiopathic Pulmonary Fibrosis (US/EU)
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder associated with progressive inflammation and/or fibrosis of the lung tissue. The leading cause of the disorder is unknown. IPF…
Painful Diabetic Neuropathy – Unmet Need – Unmet Need – Painful Diabetic Neuropathy (US/EU)
Painful diabetic neuropathy (PDN) is a prevalent complication of chronic diabetes, inducing enduring and often intense pain, characterized by sensations of burning, stabbing, tingling, and…
Acute Lymphoblastic Leukemia – Unmet Need – Unmet Need – Relapsed or Refractory Philadelphia Chromosome-Negative ALL (US/EU)
Relapsed / refractory (R/R) Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) patients have a poor prognosis. No standard of care has been established for relapsed / refractory…
Post-Traumatic Stress Disorder – Unmet Need – Unmet Need – Moderate to Severe PTSD (US/EU)
Although multiple guidelines recommend treating post-traumatic stress disorder (PTSD) with psychotherapy first, such an approach does not suffice for many patients, necessitating the use of…
